New listings

The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, or PLCO, is a large-scale clinical trial to determine whether certain cancer screening tests reduce deaths from these cancers.

All men are at risk for developing prostate cancer. About one man in six will be diagnosed with prostate cancer during his lifetime, but only one man in 34 will die of this disease.

The major risk factors for prostate cancer include genetic, dietary, and environmental factors that effect male hormones (androgens) and make a man more susceptible to this cancer.

Knowing the risk factors for prostate cancer can help you determine if and when you want to begin prostate cancer screening. The main risk factors include:

What is screening?

More Harm Than Good?

Should you get a PSA test?

The benefits and disadvantages of prostate cancer screening.

Cryotherapy: common side effects.

Chemotherapy does not cause side effects in everyone. It causes different reactions in different people.

Difficulty getting an erection, or impotence, is a major side effect of hormone therapy for prostate cancer.

According to a recent article published in the Journal of the American Medical Association, frequent sexual activity does not increase the risk of developing prostate cancer. In fact, it appears that an increase in sexual activity may provide a protective benefit against developing prostate cancer.

Percentage of erectile dysfunction due to prostatectomy.

The TNM system is currently used for clinical staging of prostate cancer.

The stages described below are based on the most recent version (2002) of the AJCC staging manual.